Wisconsin Pharmacal, FHI contest Chartex' female condom PMA.
This article was originally published in The Gray Sheet
Executive Summary
WISCONSIN PHARMACAL SEEKS WITHDRAWAL OF CHARTEX FEMALE CONDOM PMA APPROVAL as the company concur-rently discusses with Chartex ways the two firms can collaborate in the global marketing of female condoms, according to an Aug. 11 release from WPC. The discussions could result in a merger of the two firms, the company says.